Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05626348 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Clinical Efficacy of Immunomodulators in RA Patients

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 29, 2022 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
This study includes naive patients and csDMARDs-IR RA patients, treated with different regimens such as Iguratimod combination of different csDMARDs, or csDMARD with TNF inhibitors for 24 weeks. The disease activity and drug response will be observed. The immune disorder and synovial function will be evaluated at the same time.
Trial Details
NCT Number NCT05626348
Lead Sponsor Qilu Hospital of Shandong University
Conditions
(from sponsor)		 Arthritis, Rheumatoid
Related terms Arthritis, Rheumatoid
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov